Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

3.0%

6 terminated/withdrawn out of 198 trials

Success Rate

77.8%

-8.7% vs industry average

Late-Stage Pipeline

15%

30 trials in Phase 3/4

Results Transparency

5%

1 of 21 completed trials have results

Key Signals

68 recruiting1 with results

Enrollment Performance

Analytics

N/A
48(31.4%)
Phase 2
30(19.6%)
Phase 1
26(17.0%)
Early Phase 1
19(12.4%)
Phase 3
19(12.4%)
Phase 4
11(7.2%)
153Total
N/A(48)
Phase 2(30)
Phase 1(26)
Early Phase 1(19)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (198)

Showing 20 of 198 trials
NCT07533825Not ApplicableEnrolling By Invitation

Laparoscopic Staging for Stage III Gastric Cancer

Role: collaborator

NCT06534255Phase 1Active Not Recruiting

A Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of MegaLT Injection for Treating Refractory Thrombocytopenia Following Radiotherapy, Chemotherapy, or Transplantation.

Role: lead

NCT07523464Phase 1Not Yet Recruiting

Centrally Confined 8Gy/1f to Tumor Core Followed by Concurrent Chemoradiotherapy for Unresectable Stage III NSCLC

Role: lead

NCT07195084Not ApplicableRecruiting

To Explore the Safety and Efficacy of Hypervision Proton Surgery for Early-stage Non-small Cell Lung Cancer

Role: collaborator

NCT06321198Not ApplicableRecruiting

A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD

Role: lead

NCT05029141Phase 2Active Not Recruiting

New Double Epigenetic Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Role: collaborator

NCT07481656Phase 4Not Yet Recruiting

Effects of Recombinant Human Growth Hormone in Elderly Patients With Moderate to Severe Acute Brain Injury (GH-ABI-RCT)

Role: lead

NCT07462676Not ApplicableNot Yet Recruiting

Simultaneous Vs Staged VPS and CP :A Multi-cnter RCT.

Role: lead

NCT07446452Phase 2Recruiting

Disitamab Vedotin Plus Bevacizumab in HER2-Low Metastatic Breast Cancer After T-DXd Failure: A Phase II Study

Role: collaborator

NCT07130955Not ApplicableEnrolling By Invitation

A Randomized Trial of Six-Channel RF Ablation System for Renal Denervation in Uncontrolled Hypertension and Chronic Kidney Disease

Role: collaborator

NCT07211048Not ApplicableRecruiting

Anti CD19 Gene Therapy for B-cell Lymphoma

Role: lead

NCT07349576Not ApplicableCompleted

Precision Dietary Intervention Improves Postoperative Energy Intake, Nutritional Status, and Recovery in Patients Undergoing Hepatectomy for Liver Cancer: A Randomized Controlled Trial

Role: lead

NCT05348668Phase 2Completed

Hybrid Dose-fraction Radiotherapy for Metastatic Non-small Cell Lung Cancer

Role: lead

NCT06294678Phase 3Active Not Recruiting

Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies

Role: lead

NCT07047456Phase 3Recruiting

Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBT

Role: lead

NCT07288749Phase 3Not Yet Recruiting

Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction.

Role: collaborator

NCT07231770Not ApplicableRecruiting

Sulfamethoxazole Prophylaxis Duration After Renal Transplantation

Role: lead

NCT07279844Not Yet Recruiting

An Open-label, Observational, Long-term Follow-up Study Evaluating the Safety and Efficacy of RGL-193 Putamen Injection in Patients With Primary Parkinson's Disease

Role: lead

NCT03763448Not ApplicableCompleted

Infrapatellar Fat Pad Preservation Versus Resection on Clinical Outcomes After Total Knee Arthroplasty(IPAKA)

Role: collaborator

NCT07208344Early Phase 1Recruiting

Intravenous Infusion of Umbilical Cord Blood as an Adjunctive Treatment for Alzheimer's Disease

Role: lead